A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART (R) Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Autores de IIS La Fe

• Pau Montesinos Fernández

  Autor

Participantes ajenos a IIS La Fe

• Wei, Andrew H.
• Fong, Chun Yew
• Calbacho, Maria
• Gil, Jordi Sierra
• Perez De Oteyza, Jaime
• Rowe, Jacob M.
• Wolach, Ofir
• Ofran, Yishai
• Moshe, Yakir
• Sun, Jichao
• Baughman, Jan
• McNulty, Eileen
• Bonvini, Ezio
• Wigginton, Jon M.
• Davidson-Moncada, Jan K.

Grupos

• Hematología y Hemoterapia

Abstract

Abstract no disponible